Transform Type 2: Examining Meal-Delivery and Education for Diabetes Self-Care
NCT ID: NCT04810026
Last Updated: 2022-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2021-05-03
2021-10-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus
NCT06465693
The Effect of 360 Video and MAPS on Enrollment in the DPP
NCT04746781
Continuous Glucose Monitoring and Behavioral Change Intervention for People With Type 2 Diabetes and Diabetes Distress
NCT05941000
Evaluation of Video On-Demand Programming to Prevent Type 2 Diabetes in Adults
NCT01768546
Web-Delivered Interventions for Blood Sugar Control for Individuals With Type 2 Diabetes
NCT02676648
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: Education only
Push notifications for online diabetes self-management education for 12 weeks, passive access to lifestyle education for 16 weeks
Education
Healthy-lifestyle and diabetes-related virtual education (text and videos)
Group 2: Education and Meals
Meal delivery (3 meals per day, 5 days per week) for 12 weeks, push notifications for online diabetes self-management education for 12 weeks, passive access to lifestyle education for 16 weeks
Education
Healthy-lifestyle and diabetes-related virtual education (text and videos)
Meal delivery
breakfast, lunch, and dinner adhering to the longevity diet macro-nutrient profiles
Group 3: Education, Meals, Coaching
Meal delivery (3 meals per day, 5 days per week) for 12 weeks, coaching program (e.g., diabetes-specific coaching and education, push notifications for lifestyle education modules, community support) for 12 weeks, and passive access to lifestyle education for final 4 weeks
Education
Healthy-lifestyle and diabetes-related virtual education (text and videos)
Meal delivery
breakfast, lunch, and dinner adhering to the longevity diet macro-nutrient profiles
Lifestyle coaching
calls with coach and/or nutritionist, access to Facebook community support group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education
Healthy-lifestyle and diabetes-related virtual education (text and videos)
Meal delivery
breakfast, lunch, and dinner adhering to the longevity diet macro-nutrient profiles
Lifestyle coaching
calls with coach and/or nutritionist, access to Facebook community support group
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be diagnosed with type 2 diabetes, prediabetes, and/or have an A1c result of 5.7 percent or above
* Be above an ideal weight (for example, body mass index \[BMI\] greater than or equal to 25)
* 18 years of age or older
* Have UnitedHealthcare insurance for 1 year+
* Have an active e-mail address
* Have a smartphone with access to the internet that is compatible with the Dexcom G6 app
Exclusion Criteria
* Be pregnant or breastfeeding
* Have allergies to nightshade vegetable (e.g., bell peppers, potatoes, tomatoes) or legumes (e.g., green beans, peas), or tree nuts
* Currently taking anti-psychotic medications to control schizophrenia and bipolar disorders, as well as other mental disorders including dementia, major depression, and even drug addiction
* Be currently taking insulin
* Be currently taking sulfonylureas
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UnitedHealth Group
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shane Hoversten
Senior Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katlyn A Fleming, PhD
Role: PRINCIPAL_INVESTIGATOR
UnitedHealth Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OptumLabs
Minnetonka, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-0068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.